Robotics
CyberKnife System Extracranial Treatments Grow 75 Percent in Fiscal Year 2007 Demonstrating Radiosurgery Market Shift
Published in Medical Letter on the CDC and FDA, August 26th, 2007
Accuray Incorporated (NASDAQ:ARAY), a global leader in the field of radiosurgery, announced that use of its CyberKnife(R) Robotic Radiosurgery System to treat extracranial tumors non-invasively has increased by 75 percent worldwide during Accuray's fiscal year ending June 30, 2007. The most dramatic growth was seen in the treatment of lung and prostate cancer in the United States, which doubled and quadrupled respectively since the end of fiscal year 2006.
For more than four decades, radiosurgery has been used exclusively to treat brain tumors. With U.S. Food and Drug Administration clearance in 2001, the CyberKnife System became the first and only robotic radiosurgery...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Bioterrorism
Anthrax bacterium's deadly secrets probed - Bioterrorism
UC San Diego Fighting Terrorism on the Medical Front - Plague
Scientists Link E. coli Bacteria to Crohn’s Disease - Plague
UCF research links proteins, stem cells and potential Alzheimer's treatment - Regulatory Actions
UK government unlikely to meet MRSA targets - Stem Cell Research
Not all embryonic stem cell lines are created equal - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
